Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older
- People who have had an intra-aortic balloon pump (a device placed in the aorta to help the heart pump blood) in place for more than 48 hours
- People receiving a heart-stimulating medication called dobutamine at a low dose (no more than 20 mcg/kg/min)
- People receiving a blood pressure-supporting medication called norepinephrine at a low dose (no more than 0.2 mcg/kg/min)
- People who have not had any device problems or bleeding episodes in the past 24 hours
- People whose average blood pressure is within a specific range (between 60 and 120 mmHg)
- People whose heart rate is within a specific range (between 60 and 120 beats per minute)
- People who have not had a brain or nervous system event that left lasting thinking or movement problems
- People who have an untreated blood clot in a deep vein
- People with no history of autoimmune disease (conditions where the immune system attacks the body)
- People with no history of rheumatic disease (conditions affecting the joints, muscles, or connective tissue)
Who may not be able to join:
- People who need a breathing machine (invasive mechanical ventilation) to support their breathing
- People — or whose responsible family member — have not signed the informed consent form, or who have withdrawn their consent to participate
- People whose norepinephrine dose needs to increase above 0.2 mcg/kg/min during the trial
- People who develop a sudden, serious irregular heart rhythm that causes unstable blood pressure or circulation
- People whose blood pressure or heart rate moves outside the required ranges during the trial
- People who experience a new brain or nervous system event that causes thinking or movement problems during the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Rafael M Ianotti, PT, Instituto do Coração - Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
Phone: +55 11 26615319
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To investigate echo intensity of the rectus femoris muscle.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.